Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is 3-D Imaging Technology Superior to Computed Tomography in Assessing Response to Neoadjuvant Treatment in Patients With Borderline or Locally Advanced Pancreatic Adenocarcinoma?

NCT06582342 is registered in ClinicalTrials.gov with Fundación para la Investigación del Hospital Clínico de Valencia as lead sponsor.

NCT NCT06582342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06582342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is 3-D Imaging Technology Superior to Computed Tomography in Assessing Response to Neoadjuvant Treatment in Patients With Borderline or Locally Advanced Pancreatic Adenocarcinoma?
Lead sponsor
Fundación para la Investigación del Hospital Clínico de Valencia
Phase
Observational
Overall status
Recruiting
Start date
March 21, 2024
Completion date
November 30, 2026
Enrollment
70 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the pancreas